
U.S. House Speaker Nancy Pelosi will not bring her sweeping drug pricing bill to the floor for a vote this month as previously expected, according to a Senior Democratic aide.
Pelosi’s office is awaiting the final review from the non-partisan Congressional Budget Office, which measures the bill’s impact on federal spending. That is now expected to take two more weeks, according to the aide.